compound · derived
Atezolizumab
10 trials · 1 approval
| Trials | 10 |
|---|---|
| Approvals | 1 |
| Phases | Phase 1, Phase 2, Phase 2, Phase 2, Phase 3, Phase 3 |
Provenance
- Source: Derived from ClinicalTrials.gov and openFDA
- Fetched at: 2026-10-28T03:28:37.280Z
- Licence class: internal-only
- Verdict: derived
- Entity id: atezolizumab
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.